Design Inspirations
Where We Work
Academia
Atypical Models
Corporate-Affiliated
Independent
Industry/Research
Multidisciplinary
Military/Public Health
Ownership Models
Specialty Services
Students
2024 Graduation
Growth Strategies
ABB Optical Group
Alcon
Astellas
Avulux
Bausch + Lomb
EssilorLuxottica Eye Care
EssilorLuxottica: Ophthalmic Lens Products
HELIX
Johnson & Johnson Vision
L’Amy America
Lumenis
Marco
National Vision
Target Optical
Visioneering Technologies
Walmart/Sams Club Community ODs
News & Views
News
Views
Polls
Events
2024 Women’s Leadership Conference
Newsmakers
WO Resources
1 Minute Tips
Beauty
Building a Specialty
Health and Wellness
Promoting Yourself
Trending
Webinars
WO Voices Podcasts
Your Money
Jobs
Practice Staff
Opticians
Non-Optical Staff
Subscribe to WO!
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Women In Optometry
Design Inspirations
Where We Work
Academia
Atypical Models
Corporate-Affiliated
Independent
Industry/Research
Multidisciplinary
Military/Public Health
Ownership Models
Specialty Services
Students
2024 Graduation
Growth Strategies
ABB Optical Group
Alcon
Astellas
Avulux
Bausch + Lomb
EssilorLuxottica Eye Care
EssilorLuxottica: Ophthalmic Lens Products
HELIX
Johnson & Johnson Vision
L’Amy America
Lumenis
Marco
National Vision
Target Optical
Visioneering Technologies
Walmart/Sams Club Community ODs
News & Views
News
Views
Polls
Events
2024 Women’s Leadership Conference
Newsmakers
WO Resources
1 Minute Tips
Beauty
Building a Specialty
Health and Wellness
Promoting Yourself
Trending
Webinars
WO Voices Podcasts
Your Money
Jobs
Practice Staff
Opticians
Non-Optical Staff
Subscribe to WO!
Home
Tags
Progressive vision loss
Tag: progressive vision loss
Astellas
Having the Difficult Discussion With Patients on Geographic Atrophy
As one of the ODs at Ohio’s Cincinnati Eye Institute, Mary Beth Yackey, OD, often sees patients with progressing ocular diseases. Patients who are...
Astellas
Iveric Bio Receives U.S. FDA Approval for IZERVAY™ (avacincaptad pegol intravitreal...
– IZERVAY is the only approved GA treatment with a statistically significant reduction in the rate of GA progression at the 12-month primary endpoint across...
- Advertisement -
Trending Now
Editorial
Impact of Makeup on the Ocular Surface and Dry Eye Disease
Design Inspirations
Prioritizing Personalized Service
Design Inspirations
Cold-start Practice is Worth the Wait
Design Inspirations
Their Practice, Their Way
- Advertisment -